Drug discovery platform Exscientia sets terms for $275 million US IPO

Robert Marcus
Sep 27, 2021

Related news

Oct 13
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

AION Labs, Biotech Innovation Lab Launched by Top Pharma, Tech and Investment Leaders

Nov 7
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Google’s New Company Will Discover Medicines Via Artificial Intelligence & Save Lives

Mar 15
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Innovation at the intersection of design and technology

Nov 7
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

CapitalVX: A machine learning model for startup selection and exit prediction

Oct 18
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Gartner survey of CIOs highlights investments in AI, cloud and cybersecurity

Sep 16
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Gathering Strength, Gathering Storms: The One Hundred Year Study on Artificial Intelligence (AI100) 2021 Study Panel Report

Sep 21
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Artificial intelligence a key challenge for Germany's next government

Nov 23
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

AI Software Market Set to Reach New Heights Next Year

Sep 9
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Gates Foundation pours cash into British firm Exscientia to fight pandemics

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Morocco’s Mohammed VI Polytechnic University and ALPHA10X Sign Research and Development Partnership Agreement

Mar 2
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

ALPHA10X : de l’IA pour réduire le risque lié à l’investissement dans les sciences de la vie

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Innovative AI-powered Search and Discovery Platform; Interview With Robert Marcus